Paris, France (PANA) - France has welcomed the agreement between the pharmaceutical company, Gilead and the Community patent for drugs, which will allow AIDS patients more access to antiretroviral (ARV) medication in developing countries, spokesman for the French Ministry of Foreign Affairs, Bernard Valero, said here Wednesday.
Full text...©-Panapress-13 july 2011 17:19:36-thread Health (185words)